realizing the potential of tyk2 inhibition to address the burden of psoriasis
Published 1 year ago • 505 plays • Length 49:11Download video MP4
Download video MP3
Similar videos
-
37:46
the tyk2 pathway as a novel nonbiologic oral therapeutic option in moderate to severe psoriasis
-
58:51
taking aim at the tyk2 pathway in psoriasis
-
1:02:10
fine-tuning the jak/stat pathway in psoriasis
-
11:27
diagnosis and treatment of tnf inhibitor-induced psoriasis
-
2:23
the future of tyrosine kinase inhibitors for melanoma and open questions
-
1:01:26
drs. armstrong & gordon discuss the latest psoriasis updates from #aad2021 https://bit.ly/3mr1fto
-
5:01
efficacy and safety of selective tyk2 inhibitor, deucravacitinib, trial in psoriatic arthritis
-
9:55
clinical trial: sparsentan for treatment of iga nephropathy
-
29:10
new directions in kinase inhibition in systemic lupus erythematosus: evidence from copenhagen
-
22:09
tyk2 inhibitors for the treatment of psoriasis | ronald vender, md, frcpc | canada
-
6:18
tyk2 inhibitors show efficacy in psoriatic arthritis - medpage today
-
33:24
how does 'refractory' skin disease affect psoriasis?
-
18:19
how to diagnose and assess severity of gpp | david burden, chb, dtm&h, md, frcp | united kingdom
-
10:49
new psoriasis treatments: jak inhibitors, tyk2 inhibitors... | what's new for psoriasis treatments
-
7:16
efficacy of il-23 inhibitors in plaque psoriasis
-
10:30
from pathophysiology to therapeutic progress: tyk2's significance in plaque psoriasis
-
5:11
use of il-23 inhibitors to treat plaque psoriasis
-
1:05:17
immunology in the perspective of comorbidities and early intervention
-
24:02
il-23 inhibitors and other emerging psoriasis treatments